These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1727981)

  • 1. Transient neutropenia induced by intravenous immune globulin.
    Ben-Chetrit E; Putterman C
    N Engl J Med; 1992 Jan; 326(4):270-1. PubMed ID: 1727981
    [No Abstract]   [Full Text] [Related]  

  • 2. Aseptic meningitis as a side effect of intravenous immune gammaglobulin.
    Lafferty TE; DeHoratius RJ; Smith JB
    J Rheumatol; 1997 Dec; 24(12):2491-2. PubMed ID: 9415672
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin-induced neutropenia.
    Khan S; Doré PC; Sewell WA
    Pediatr Allergy Immunol; 2010 Aug; 21(5):892-3. PubMed ID: 19368688
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease.
    Becker BN; Fuchs H; Hakim R
    J Am Soc Nephrol; 1995 Apr; 5(10):1746-50. PubMed ID: 7787141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of systemic lupus erythematosus with intravenous human immunoglobulins. Preliminary study].
    Migliaresi S; Gallo M; Tirri G
    Clin Ter; 1992 Sep; 141(9 Pt 2):83-4. PubMed ID: 1468203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal failure after intravenous immunoglobulin therapy.
    Pasatiempo AM; Kroser JA; Rudnick M; Hoffman BI
    J Rheumatol; 1994 Feb; 21(2):347-9. PubMed ID: 8182648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intravenous gamma-globulin in systemic lupus erythematosus.
    Oliet A; Hernández E; Gallar P; Vigil A
    Nephron; 1992; 62(4):465. PubMed ID: 1300444
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of systemic lupus erythematosus with severe neutropenia and the effect of high dose globulin therapy].
    Nagano N; Masugi F; Nakamaru M; Morimoto S; Shiraishi T; Onishi T; Ogihara T; Kumahara Y; Kurata Y
    Nihon Naika Gakkai Zasshi; 1989 Jan; 78(1):59-63. PubMed ID: 2471761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe and prolonged neutropenia at the beginning of disseminated lupus erythematosus].
    Weiller PJ; Lam My S; Patenaude JV; Horschowski N; David M; Mongin M
    Nouv Presse Med; 1982 Mar; 11(11):866. PubMed ID: 7070981
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy with systemic lupus erythematosus and four IVF failures treated with intravenous gamma globulin infusions.
    Darmochwał-Kolarz D; Leszczyńska-Gorzelak B; Putowski L; Majdan M
    Int J Gynaecol Obstet; 2004 Apr; 85(1):54-5. PubMed ID: 15050472
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus.
    Coppolino G; Campo S; Bolignano D; Sturiale A; Giacobbe MS; Loddo S; Buemi M
    Ann Rheum Dis; 2008 Jul; 67(7):1047-8. PubMed ID: 18556444
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
    Buyukhatipoglu H; Pehlivan Y; Onat AM
    Rheumatology (Oxford); 2008 Sep; 47(9):1438-9; author reply 1439-40. PubMed ID: 18658203
    [No Abstract]   [Full Text] [Related]  

  • 13. [Macrophage activation syndrome in lupus].
    Javier RM; Sibilia J; Offner C; Albert A; Kuntz JL
    Rev Rhum Ed Fr; 1993 Nov; 60(11):831-5. PubMed ID: 8054932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-related acute lung injury in a patient with systemic lupus erythematosus.
    Pelechas E; Gerolymatou N; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2017; 35(2):353. PubMed ID: 28134082
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polyvalent intravenous immunoglobulins: their use in dermatology].
    Derancourt C; Humbert P; Agache P
    Ann Dermatol Venereol; 1992; 119(6-7):487-8. PubMed ID: 1444110
    [No Abstract]   [Full Text] [Related]  

  • 18. Moderate and severe neutropenia in patients with systemic lupus erythematosus.
    Martínez-Baños D; Crispín JC; Lazo-Langner A; Sánchez-Guerrero J
    Rheumatology (Oxford); 2006 Aug; 45(8):994-8. PubMed ID: 16484291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure induced by intravenous immune globulin.
    Arunabh ; Arunabh S; Kumar G; Avila V
    Am Fam Physician; 1996 Feb; 53(3):862, 865. PubMed ID: 8594861
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of high-dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases].
    De Vita S; D'Ascanio A; Bombardieri S
    Recenti Prog Med; 1991 Nov; 82(11):603-6. PubMed ID: 1763234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.